Vitality Biopharma Advisor Will Present Pediatric IBD Case Study

Vitality Biopharma (OTCQB:VBIO) announced company advisor Dr. Natasha Ryz will be presenting at an international research symposium in Montréal.
As quoted in the press release:

Dr. Ryz will provide a poster presentation titled “Cannabinoid Treatment Induces Remission in Drug-Resistant Pediatric Inflammatory Bowel Disease: A Case Report.” The case report provides clinical results describing a 13-year old boy with drug-resistant Crohn’s disease that achieved disease remission after cannabinoid treatment. Dr. Ryz holds a Ph.D. in Experimental Medicine from the University of British Columbia, where she was a Vanier Scholar.

Click here to read the full press release.

Source: www.marketwired.com